UK markets close in 3 hours 42 minutes

Shanghai Junshi Biosciences Co., Ltd. (8SJ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.5600+0.0800 (+5.41%)
As of 11:05AM CEST. Market open.

Shanghai Junshi Biosciences Co., Ltd.

Building 7
15th Floor No.6, Lane 100, Pingjiaqiao Road Pudong New Area
Shanghai 200126
China
86 21 6105 8800
https://www.junshipharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees2,568

Key executives

NameTitlePayExercisedYear born
Mr. Jun XiongExecutive Chairman916.93kN/A1974
Mr. Cong LiCo-CEO & Executive Director543.98kN/A1964
Dr. Jianjun Zou M.D., Ph.D.GM, CEO & Executive Director754.79kN/A1971
Dr. Ning LiExecutive Vice-Chairman of the Board939.72kN/A1961
Mr. Baohong XuFinancial DirectorN/AN/A1979
Mr. Zhuobing ZhangDeputy GM & Executive Director868.25kN/A1967
Dr. Sheng Yao Ph.D.Senior VP & Executive Director597.29kN/A1975
Dr. Gang WangDeputy GM, Chief Quality Officer, Senior VP of Industry Affairs & Executive Director146.43kN/A1957
Ms. Siu Kuen Lai FCIS, FCSJoint Company SecretaryN/AN/A1976
Mr. Zhengyu WangJoint Company SecretaryN/AN/A1995
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

Corporate governance

Shanghai Junshi Biosciences Co., Ltd.’s ISS governance QualityScore as of 1 May 2024 is 8. The pillar scores are Audit: 7; Board: 9; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.